Search
Searching with a thematic focus on HIV and AIDS, HIV and AIDS treatment and care
Showing 331-340 of 1199 results
Pages
- Document
Rapid expansion, emerging challenges
Access to Essential Medicines Campaign, MSF, 2004This MSF briefing document describes some of the progress on antiretroviral therapy (ART), as well as some of the emerging operational and clinical challenges. It presents this information from the perspective of a medical humanitarian organisation that provides treatment to people living with HIV/AIDS in resource poor settings.DocumentTechnical guide for HIV/AIDS medicines and related supplies: contemporary context and procurement
World Bank, 2004This guide from the World Bank sets out principles and advice for the procurement of HIV/AIDS medicines and related supplies for scaling up antiretroviral therapy (ART) and associated health services. It is aimed at World Bank staff, as well as those responsible for procuring HIV/AIDS medicines and related supplies in Bank-funded programmes and projects.DocumentFinancing issues in proposed HIV/AIDS intervention of providing anti-retroviral drugs to selected regions in India
Indian Institute of Management, Ahmedabad, 2004The development of antiretroviral therapy has given a new hope for people living with Acquired Immuno Deficiency Syndrome (AIDS). In the face of increased disease burden due to AIDS the global and political commitment towards controlling the pandemic has received renewed thrust in recent times.DocumentAIDS In India: public health related aspects of industrial and intellectual property rights policies in a developing country
Centre de Sciences Humaines, New Delhi, 2004By 2004, an estimated 40 million people world-wide are infected by the Acquired Immuno-Deficiency Syndrome (AIDS) or the Human Immuno-Deficiency Virus (HIV). The epidemic essentially affects developing countries (DCs), and India is no exception, with reported cases numbering around 4 million.DocumentMeasuring HIV/AIDS related stigma: promising practice of stigma-mitigation from across South Africa
Policy Project, Futures Group, Washington, 2004This report from the siyam’kela project looks at three focus areas that play a crucial role in stigma mitigation. The first section looks at how faith-based organisations (FBOs) are influential in shaping values and attitudes to vulnerable people in society as well as developing compassionate responses to social challenges.DocumentAccess to medicines in under-served markets: what are the implications of changes in intellectual property rights, trade and drug registration policy?
Department for International Development Health Systems Resource Centre, 2004This research paper from the DFID Health Systems Resource Centre shows that the laws on Trade-Related Aspects of Intellectual Property (TRIPS) are having a negative effect on health systems in developing countries.The report brings together findings from seven studies commissioned by DFID on the public health implications of TRIPS for developing countries and the effect it has on access to drugDocumentNGO capacity analysis: a toolkit for assessing and building capacities for high quality responses to HIV/AIDS
International HIV/AIDS Alliance, 2004This document from the International HIV/AIDS Alliance is a toolkit for assessing and building capacities for HIV/AIDS responses.DocumentWillingness and ability to use TRIPs flexibilities: Kenya case study
Department for International Development Health Systems Resource Centre, 2004This paper, produced by the HSRC, examines legislation and policy in light of recent developments in the international intellectual property rights framework, focusing on Kenya as a case study. It examines existing supply sources and associated trends in the pricing of medicine and the existing legal structure and flexibilities.DocumentA survey of policy and practice on the use of access to medicines-related TRIPs flexibilities in Malawi
Department for International Development Health Systems Resource Centre, 2004This HSRC study surveys Malawian policy and practice on the use of access to medicines-related TRIPs (Trade Related Aspects of Intellectual Property Rights) flexibilities, as Malawian patent legislation will need to become compliant with TRIPs by January 2006.DocumentEmerging challenges and opportunities in drug registration and regulation in developing countries
Department for International Development Health Systems Resource Centre, 2004This HSRC study describes how current drug regulation and registration processes affect the quality and availability of medicines in developing countries, and provides policy recommendations as to how systems can more efficiently allow appropriate quality drugs to market.Pages
